655 Elizabeth Street
Melbourne, VIC 3000
Australia
61 3 9389 1911
https://www.csl.com.au
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 32.065
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Paul F. McKenzie Ph.D. | MD, CEO & Executive Director | 4,24M | N/A | 1966 |
Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI | Chief Financial Officer | 3,15M | N/A | 1965 |
Mr. Mark Dehring | Head of Investor Relations | N/A | N/A | N/A |
Mr. Gregory Boss B.S., BS(Hons), J.D. | Executive VP of Legal & General Counsel | 1,69M | N/A | 1961 |
Christina Hickie | Senior Manager of Communications | N/A | N/A | N/A |
Ms. Roanne Parry | Chief Human Resources Officer | N/A | N/A | N/A |
Dr. Karen Etchberger | Executive Vice President of Quality & Business Services | 1,59M | N/A | 1958 |
Ms. Jemimah Brennan | Head of Communications - Asia Pacific | N/A | N/A | N/A |
Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D. | Senior Vice President of Research | N/A | N/A | 1962 |
Dr. William Mezzanotte M.D., M.P.H. | Executive VP & Head of Research and Development | 2,24M | N/A | 1959 |
O QualityScore de governança da ISS da CSL Limited a partir de 1 de abril de 2024 é 2. As principais pontuações para Auditoria são: 4; Conselho: 4; Direitos de Acionistas: 1; Compensação: 4.